Regina E. Herzlinger - Publications - Faculty & Research - Harvard Business School

Filter Results: (704)

Filter Results: (704)

Show Results For

← Page 24 of 704 Results →

February 18, 2022
Article

Transparency as a Solution for COVID-19 Related Hospital Capacity Issues

By: Regina E. Herzlinger and Richard Boxer

In the initial phases of the COVID-19 pandemic, many U.S. hospitals could not provide an adequate supply of beds to meet demand. Solving the problem of hospital bed capacity is of great importance in the “new normal,” which requires recognizing that SARS-CoV-2 is but... View Details

Keywords: COVID; COVID-19 Pandemic; Health Care; Health Care Demand; Health Care Delivery; Health Care Industry; Health Care Operations; Health Care Policy; Transparency; Hospital; Hospital Management; Hospitals; Health Pandemics; Health Care and Treatment; Service Delivery; Operations; Performance Capacity; Policy; Health Industry

Article

Ten Year Sunset Rule for Healthcare Regulation Is a Nonstarter and Discouragement to Post-COVID-19 Investment

By: Regina E. Herzlinger and Eugene Schneller

U.S. healthcare delivery has not benefitted from the same productivity growth as many other service industries, such as bricks and mortar retailing, a loss that has gravely diminished cost control and access. Regulatory capture, which creates barriers to venture... View Details

Keywords: Health Care; COVID-19; Regulation; Health Care and Treatment; Health Pandemics; Governing Rules, Regulations, and Reforms; Investment

8 Sep 2020
Interview

The U.S. Health Care System: From Dysfunction to Functioning

By: Regina E. Herzlinger and Edward Shin

February 2018
Case

Health Savings Accounts: Enabling Consumer Participation

By: Regina E. Herzlinger and James Wallace

Health savings accounts (HSAs), a creation of the 2003 Medicare Modernization Act, had become an integral part of the drive toward consumer-driven health care. Coupled with high-deductible health plans, HSAs allowed consumers to directly control a significant part of... View Details

Keywords: Health Care; Healthcare Costs; Health Insurance; Health Care and Treatment; Cost; Insurance; Innovation and Invention; Health Industry; United States

March 2015 (Revised February 2022)
Supplement

CV Ingenuity (B): Epilogue

By: Regina E. Herzlinger and Andrew Otazo

Duke Rohlen used a lea-nfunding, iconoclastic strategy for his start up for a drug eluding balloon for peripheral artery disease. His giant competitors were first movers. Did Duke obtain the funding he sought? How did his DEB fare versus that of his competitors? The... View Details

March 2015 (Revised January 2024)
Case

CV Ingenuity (A): How to Evaluate the Commercial Viability of New Health Care Technologies

By: Regina E. Herzlinger and Andrew Otazo

Duke Rohlen (HBS MBA ’01) hoped to win over a prominent venture capital investor for Series B financing of his firm CVI that was creating a drug-eluting balloon (DES) to treat peripheral arterial disease. As a second-mover, Duke felt he was more likely to acquire... View Details

April 1995 (Revised August 1995)
Supplement

Empire Blue Cross and Blue Shield (D)

By: Regina E. Herzlinger and Ramona Hilgenkamp

Supplements the (A) case. View Details

Keywords: Insurance Industry; Health Industry

April 1995 (Revised December 2006)
Case

Identify the Nonprofit

By: Regina E. Herzlinger and Ramona Hilgenkamp

This case presents financial statements and selected ratios for seven unidentified nonprofit organizations and asks that each set of financial information be matched with one of the following nonprofit entities: a public television station, a suburban hospital, a... View Details

Keywords: Nonprofit Organizations; Financial Statements

February 1995
Background Note

Health Information Industry Note

By: Regina E. Herzlinger and VJ Pappas

Keywords: Health; Information

Find at Harvard

May 2014
Case

Health Care Accountability: Examples in Cancer Treatment

By: Regina E. Herzlinger and Natalie Kindred

This case is designed to support a discussion of the importance of outcomes evidence in empowering the public to make better health care decisions, the desired level of transparency and accountability for health care providers, and the issues with current measuring and... View Details

Keywords: Accountability; Health Care; Cancer; Cancer Treatment; Memorial Sloan Kettering Cancer Center; Cancer Treatment Centers Of America; Vantage Oncology; Radiology; Risk Adjustment; Treatment Outcomes; Health Care Outcomes; Prostate Cancer; Transparency; Health Care and Treatment; Risk Management; Outcome or Result; Health Industry; United States

March 2014 (Revised September 2014)
Supplement

Cancer Treatment Centers of America® (B)

By: Regina E. Herzlinger and Natalie Kindred

This case, a follow-up to Cancer Treatment Centers of America (A), HBS No. 313-012, begins with the debate over New Hampshire's certificate-of-need (CON) law, which restricts hospital expansion. This debate ignited significant public criticism of Cancer Treatment... View Details

Keywords: Cancer; Cancer Treatment; Accountability; Outcomes; Outcomes Reporting; Outcomes Measurement; Survival; For-profit Hospitals; Health Care; Healthcare; Hospital; Certificate Of Need; Health Care and Treatment; Outcome or Result; Corporate Accountability; Policy; Health Industry; United States

August 2013 (Revised August 2014)
Technical Note

Population Health Management—Techniques and Tools

By: Regina E. Herzlinger and Kyle Bertke

Companion note to "Amil and the Health Care System in Brazil," Harvard Business School Case No. 312-029, January 2014 View Details

March 2010
Supplement

Boston Scientific Corporation (B)

By: Regina E. Herzlinger and Charlie Attlan

The case provides the denoument for Boston Scientific Corporation (A) HBS No. 310079. View Details

Keywords: Medical Devices and Supplies Industry

March 2008 (Revised January 2010)
Background Note

Note on Accountability in the U.S. Health Care System

By: Regina E. Herzlinger and Michael Millenson

This note explains how health care providers, health insurers, and consumers are held accountable for their performance and the entrepreneurial opportunities thus created. View Details

Keywords: Entrepreneurship; Ethics; Insurance; Corporate Accountability; Health Care and Treatment; Demand and Consumers; Health Industry; United States

February 2008 (Revised August 2012)
Background Note

Note on Medical Travel

By: Regina E. Herzlinger and Sara Green

Background notes for MedVal and Fortis case studies. View Details

Keywords: Cost; Health Care and Treatment; Cross-Cultural and Cross-Border Issues; Health Industry; Tourism Industry; India

June 2005 (Revised August 2006)
Exercise

New Sector Alliance (B)

By: Regina E. Herzlinger and Louisa Neissa

Supplements the (A) case. View Details

Keywords: Health Care and Treatment; Policy; United States

Find at Harvard

June 2003 (Revised March 2008)
Case

Schering-Plough and Genome Therapeutics: Discovering an Asthma Gene

By: Regina E. Herzlinger and Marc Aquino

Personalized medicine requires the identification of mutated genes. Schering-Plough's search for the one related to asthma requires finding families with the disease. Examines the industry that helps conduct such research, including contract research organizations. View Details

Keywords: Health Disorders; Research and Development; Genetics; Biotechnology Industry; Pharmaceutical Industry

September 2002 (Revised January 2013)
Case

MedCath Corporation (A)

By: Regina E. Herzlinger and Pete Stavros

MedCath is a horizontally integrated chain of heart hospitals that partners with local cardiologists. It claims that its focus leads to better and cheaper results than those of an everything-for-everybody general hospital. Community hospitals generally vehemently... View Details

Keywords: Medical Specialties; Market Entry and Exit; Service Delivery; Conflict and Resolution; Horizontal Integration; Health Industry

August 2012 (Revised August 2012)
Case

HealthAllies (A)

By: Regina E. Herzlinger and Michael Sherman

This case describes a "do good and do well" firm that enables individuals to buy health care services at discounted prices. It delineates the characteristics of the uninsured and others who are the primary targets for the firm. "HealthAllies (B)" provides information... View Details

Keywords: Entrepreneurship; Health Care and Treatment; Marketing Channels; Demand and Consumers; Commercialization; Health Industry

08 Dec 2003
Research & Ideas

Why Europe Lags in Pharmaceuticals and Biotech

pharma," said HBS professor Regina Herzlinger, moderating a panel discussion titled "Pharma and Biotech—Where does Europe Stand in the World?" The discussion was held at the conference on November 22. At the start of the... View Details

Keywords: by Sean Silverthorne; Biotechnology; Health; Pharmaceutical; Technology

←
24
25
…
35
36
→